You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME/CE

In My Practice: Aesthetic Neurotoxin Treatment of the Upper Face

  • Authors: Jeffrey S. Dover, MD
  • CME/CE Released: 4/27/2011
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 4/27/2012, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This activity is intended for dermatologists, plastic surgeons, primary care providers, and nurses who are involved in aesthetic procedures.

The goal of this activity is to review the principles of aesthetic neurotoxin treatment of the upper face.

Upon completion of this activity, participants will be able to:

  1. Describe the principles of safe and effective aesthetic neurotoxin treatment of the upper face
  2. Design strategies to treat the upper face with neurotoxins


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • Jeffrey S. Dover, MD

    SkinCare Physicians, Chestnut Hill, Massachusetts

    Disclosures

    Disclosure: Jeffrey S. Dover, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Iridex Corporation; Lumenis; Medicis Pharmaceutical Corporation; Solta Medical; Zeltiq Aesthetics, Inc.
    Received grants for clinical research from: Allergan, Inc; Bella Contour; Boston Biocom; Iridex Corporation; Kythera Biopharmaceuticals; Lumenis; Medicis Pharmaceutical Corporation; Merz Pharmaceuticals; Palomar Medical Technologies; Shaser, Inc; Solta Medical; Suneva Medical, Inc; Syneron Medical Ltd; Zeltiq Aesthetics, Inc
    Has received the use of equipment from: Cynosure, Inc; Iridex Corporation; Lumenis; Opusmed, Inc; Palomar Medical Technologies; Solta Medical; Syneron Medical Ltd
    Owns stock, stock options, or bonds from: CVS/Skin Effects, Shaser Inc

    Dr. Dover does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr. Dover does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

  • Kristin M. Richardson

    Senior Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Kristin M. Richardson has disclosed no relevant financial relationships.

CME Reviewer

  • Nafeez Zawahir, MD

    CME Clinical Director, Medscape, LLC

    Disclosures

    Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Nurse Planner

  • Laurie E. Scudder, DNP, NP

    Nurse Planner, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing and Allied Health, George Washington University, Washington, DC

    Disclosures

    Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

    For Nurses

  • Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.

    Accreditation of this program does not imply endorsement by either Medscape, LLC or ANCC.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. Medscape Education encourages you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CME/CE

In My Practice: Aesthetic Neurotoxin Treatment of the Upper Face

Authors: Jeffrey S. Dover, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME/CE Released: 4/27/2011

Valid for credit through: 4/27/2012, 11:59 PM EST

processing....

 
 
 
 

Editor's note:
Medscape Education attempts to use generic names for drugs and devices whenever possible. In this program, the trade names for the 2 commercially available botulinum neurotoxin type A (BoNTA) products for aesthetic use are used for clarity. The use of trade names should not be viewed as an endorsement by Medscape Education of specific products. This program discusses off-label uses of BoNTA products.

This feature requires the newest version of Flash. You can download it here.

Supported by an independent educational grant from Medicis Pharmaceutical Corporation.

  • Print